Structure and ligand interactions of the urokinase receptor (uPAR)

Frontiers in Bioscience

Volumn 13, Issue 14, 2008, Pages 5441-5461

  Kjaergaard, Magnus ^a,b   Hansen, Line V ^a,c   Jacobsen, Benedikte ^a   Gardsvoll, Henrik ^a   Ploug, Michael ^a  

^a FINSEN LABORATORY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c DrugMode ApS   (Denmark)

Author keywords

Alpha neurotoxin; ANS; C4.4A; Cancer; CD87; Gene cluster; GPI; LU domain; LYPD; Multidomain; PLAUR; PRO4356GPQH2552; PRV 1; Review; SMB; TEX 101; Three finger fold; UPA; Vitronectin

Indexed keywords

SUID HERPESVIRUS 1;

CELL SURFACE RECEPTOR; LIGAND; UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTORS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTORS; VITRONECTIN;

AMINO ACID SEQUENCE; ARTICLE; CELL MEMBRANE; CHEMISTRY; GENETICS; GLYCOSYLATION; HUMAN; METABOLISM; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN FOLDING;

AMINO ACID SEQUENCE; CELL MEMBRANE; CONSERVED SEQUENCE; GLYCOSYLATION; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; LIGANDS; MULTIGENE FAMILY; PROTEIN CONFORMATION; PROTEIN FOLDING; RECEPTORS, CELL SURFACE; VITRONECTIN;

EID: 52049086879     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3092     Document Type: Review

References (142)

1. Page-McCaw, A., Ewald, A.J. & Werb, Z.: Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol, 8, 221-33 (2007)
2. Dano, K., Behrendt, N., Hoyer-Hansen, G., Johnsen, M., Lund, L., Ploug, M. & Romer, J.: Plasminogen activation and cancer. Thromb Haemost., 93, 676-81 (2005) (Pubitemid 40485402)
3. Romer, J., Bugge, T., Pyke, C., Lund, L., Flick, M., Degen, J. & Dano, K.: Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med., 2, 287-92 (1996) (Pubitemid 26080649)
4. Lund, L., Green, K., Stoop, A., Ploug, M., Almholt, K., Lilla, J., Nielsen, B., Christensen, I., Craik, C., Werb, Z., Dano, K. & Romer, J.: Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J., 25, 2686-97 (2006) (Pubitemid 43980377)
5. Ellis, V., Scully, M.F. & Kakkar, V.V.: Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem, 264, 2185-8 (1989) (Pubitemid 19057691)
6. Ellis, V. & Dano, K.: Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation. J. Biol. Chem., 268, 4806-4813 (1993) (Pubitemid 23081597)
7. Kobayashi, H., Schmitt, M., Goretzki, L., Chucholowski, N., Calvete, J., Kramer, M., Günzler, W., Janicke, F. & Graeff, H.: Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (ProuPA). J. Biol. Chem., 266, 5147-5152 (1991) (Pubitemid 21909471)
8. Lee, S.-L., Dickson, R.B. & Lin, C.-Y.: Activation of Hepatocyte Growth Factor and Urokinase/Plasminogen Activator by Matriptase, an Epithelial Membrane Serine Protease J. Biol. Chem., 275, 36720-36725 (2000) (Pubitemid 32002078)
9. Kilpatrick, L.M., Harris, R.L., Owen, K.A., Bass, R., Ghorayeb, C., Bar-Or, A. & Ellis, V.: Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase Blood, 108, 2616-2623 (2006)
10. Moran, P., Li, W., Fan, B., Vij, R., Eigenbrot, C. & Kirchhofer, D.: Pro-urokinase-type Plasminogen Activator Is a Substrate for Hepsin. J. Biol. Chem., 281, 30439-30446 (2006) (Pubitemid 44596152)
11. Lijnen, H.: Gene targeting in hemostasis. alpha2-antiplasmin. Front Biosci. 6, D239-47 (2001)
12. Ragno, P.: The urokinase receptor: a ligand or a receptor? Story of a sociable molecule. Cellular and Molecular Life Sciences (CMLS), 63, 1028-1037 (2006) (Pubitemid 43800773)
13. Blasi, F. & Carmeliet, P.: uPAR: A verstile signalling orchestrator. Nat Rev Mol Cell Biol, 3, 932-943 (2002)
14. Roldan, A., Cubellis, M., Masucci, M., Behrendt, N., Lund, L., Dano, K., Appella, E. & Blasi, F.: Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO Journal, 9, 467-74 (1990)
15. Engelholm, L.H. & Behrendt, N.: Differential binding of urokinase and peptide antagonists to the urokinase receptor: evidence from characterization of the receptor in four primate species. Biol Chem, 382, 435-42 (2001) (Pubitemid 32372487)
16. Fowler, B., Mackman, N., Parmer, R.J. & Miles, L.A.: Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR. Thromb Haemost, 80, 148-54 (1998) (Pubitemid 28353513)
17. Krätzschmar, J., Haendler, B., Kojima, S., Rifkin, D.B. & Schleuning, W.D.: Bovine urokinase-type plasminogen activator and its receptor: cloning and induction by retinoic acid. Gene, 125, 177-83 (1993)
18. Kristensen, P., Eriksen, J., Blasi, F. & Dano, K.: Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract. J Cell Biol, 115, 1763-71 (1991) (Pubitemid 21910015)
19. Rabbani, S.A., Rajwans, N., Achbarou, A., Murthy, K.K. & Goltzman, D.: Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts. FEBS Lett, 338, 69-74 (1994) (Pubitemid 24047784)
20. Ploug, M., Ronne, E., Behrendt, N., Jensen, A., Blasi, F. & Dano, K.: Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosylphosphatidylinositol. J. Biol. Chem., 266, 1926-1933 (1991) (Pubitemid 21908387)
21. Moller, L., Ploug, M. & Blasi, F.: Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator. Eur J Biochem., 208, 493-500 (1992)
22. Eisenhaber, B., Bork, P. & Eisenhaber, F.: Posttranslational GPI lipid anchor modification of proteins in kingdoms of life: analysis of protein sequence data from complete genomes Protein Eng., 14, 17-25 (2001) (Pubitemid 32318934)
23. Udenfriend, S. & Kodukula, K.: How Glycosyl-Phosphatidylinositol- Anchored Membrane Proteins are Made Annual Review of Biochemistry, 64, 563-591 (1995)
24. Lehto, M.T. & Sharom, F.J.: Proximity of the Protein Moiety of a GPI-Anchored Protein to the Membrane Surface: A FRET Study. Biochemistry, 41, 8368-8376 (2002) (Pubitemid 34705490)
25. Chevalier, F., Lopez-Prados, J., Perez, S., Martín-Lomas, M. & Nieto, P.M.: Conformational Study of GPI Anchors: the Common Oligosaccharide GPI Anchor Backbone. European Journal of Organic Chemistry, 2005, 3489-3498 (2005) (Pubitemid 41187266)
26. Chevalier, F., Lopez-Prados, J., Groves, P., Perez, S., Martin-Lomas, M. & Nieto, P.M.: Structure and dynamics of the conserved protein GPI anchor core inserted into detergent micelles Glycobiology, 16, 969-980 (2006) (Pubitemid 44390938)
27. Suzuki, K.G., Fujiwara, T.K., Sanematsu, F., Iino, R., Edidin, M. & Kusumi, A.: GPI-anchored receptor clusters transiently recruit Lyn and G alpha for temporary cluster immobilization and Lyn activation: single-molecule tracking study 1. J Cell Biol, 177, 717-30 (2007) (Pubitemid 46799842)
28. Zhang, F., Crise, B., Su, B., Hou, Y., Rose, J., Bothwell, A. & Jacobson, K.: Lateral diffusion of membrane-spanning and glycosylphosphatidylinositollinked proteins: toward establishing rules governing the lateral mobility of membrane proteins J. Cell Biol., 115, 75-84 (1991) (Pubitemid 21909895)
29. Myohanen, H., Stephens, R., Hedman, K., Tapiovaara, H., Ronne, E., Hoyer-Hansen, G., Dano, K. & Vaheri, A.: Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. J. Histochem. Cytochem., 41, 1291-1301 (1993) (Pubitemid 23239093)
30. Schnitzer, J.E., McIntosh, D.P., Dvorak, A.M., J., L. & Oh, P.: Separation of caveolae from associated microdomains of GPI-anchored proteins. Science, 269, 1435-1439 (1995)
31. Bohuslav, J., Horejsi, V., Hansmann, C., Stockl, J., Weidle, U., Majdic, O., Bartke, I., Knapp, W. & Stockinger, H.: Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes J. Exp. Med., 181, 1381-1390 (1995)
32. Stahl, A. & Mueller, B.: The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae J. Cell Biol., 129, 335-344 (1995)
33. Cunningham, O., Andolfo, A., Santovito, M.L., Iuzzolino, L., Blasi, F. & Sidenius, N.: Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J., 22, 5994-6003 (2003) (Pubitemid 37463243)
34. Ploug, M., Plesner, T., Ronne, E., Ellis, V., Hoyer-Hansen, G., Hansen, N.E. & Dano, K.: The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood, 79, 1447-55 (1992)
35. Hill, A., Richards, S.J. & Hillmen, P.: Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria. Br J Haematol, 137, 181-92 (2007) (Pubitemid 46537635)
36. Ploug, M., Eriksen, J., Plesner, T., Hansen, N.E. & Dano, K.: A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria. Eur J Biochem, 208, 397-404 (1992)
37. Nielsen, L., Kellerman, G., Behrendt, N., Picone, R., Dano, K. & Blasi, F.: A 55, 000-60, 000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification. J. Biol. Chem., 263, 2358-2363 (1988) (Pubitemid 18060297)
38. Behrendt, N., Ronne, E., Ploug, M., Petri, T., Lober, D., Nielsen, L., Schleuning, W., Blasi, F., Appella, E. & Dano, K.: The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. J. Biol. Chem., 265, 6453-6460 (1990)
39. Estreicher, A., Wohlwend, A., Belin, D., Schleuning, W. & Vassalli, J.: Characterization of the cellular binding site for the urokinase-type plasminogen activator. J. Biol. Chem., 264, 1180-1189 (1989) (Pubitemid 19038109)
40. Ploug, M., Rahbek-Nielsen, H., Nielsen, P.F., Roepstorff, P. & Dano, K.: Glycosylation Profile of a Recombinant Urokinase-type Plasminogen Activator Receptor Expressed in Chinese Hamster Ovary Cells J. Biol. Chem., 273, 13933-13943 (1998) (Pubitemid 28268448)
41. Nilsson, I. & von Heijne, G.: Glycosylation Efficiency of Asn-Xaa-Thr Sequons Depends Both on the Distance from the C Terminus and on the Presence of a Downstream Transmembrane Segment J. Biol. Chem., 275, 17338-17343 (2000) (Pubitemid 30430768)
42. Gardsvoll, H., Werner, F., Sondergaard, L., Dano, K. & Ploug, M.: Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites. Protein Expression and Purification, 34, 284-295 (2004) (Pubitemid 38390578)
43. Llinas, P., Le Du, M.H., Gardsvoll, H., Dano, K., Ploug, M., Gilquin, B., Stura, E.A. & Menéz, A.: Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. EMBO J., 24, 1655-63 (2005) (Pubitemid 40704976)
44. Huai, Q., Mazar, A.P., Kuo, A., Parry, G.C., Shaw, D.E., Callahan, J., Li, Y., Yuan, C., Bian, C., Chen, L., Furie, B., Furie, B.C., Cines, D.B. & Huang, M.: Structure of Human Urokinase Plasminogen Activator in Complex with Its Receptor. Science, 311, 656-659 (2006) (Pubitemid 43191309)
45. Barinka, C., Parry, G., Callahan, J., Shaw, D.E., Kuo, A., Bdeir, K., Cines, D.B., Mazar, A. & Lubkowski, J.: Structural Basis of Interaction between Urokinase-type Plasminogen Activator and its Receptor. Journal of Molecular Biology, 363, 482-495 (2006) (Pubitemid 44472493)
46. Gardsvoll, H., Dano, K. & Ploug, M.: Mapping Part of the Functional Epitope for Ligand Binding on the Receptor for Urokinase-type Plasminogen Activator by Site-directed Mutagenesis J. Biol. Chem., 274, 37995-38003 (1999) (Pubitemid 30026869)
47. Moller, L., Pollanen, J., Ronne, E., Pedersen, N. & Blasi, F.: N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand. J. Biol. Chem., 268, 11152-11159 (1993) (Pubitemid 23162305)
48. Behrendt, N., Ploug, M., Patthy, L., Houen, G., Blasi, F. & Dano, K.: The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J. Biol. Chem., 266, 7842-7847 (1991) (Pubitemid 21906442)
49. Ploug, M., Kjalke, M., Ronne, E., Weidle, U., Hoyer-Hansen, G. & Dano, K.: Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipidanchored membrane proteins. J. Biol. Chem., 268, 17539-17546 (1993) (Pubitemid 23236998)
50. Hoyer-Hansen, G., Ronne, E., Solberg, H., Behrendt, N., Ploug, M., Lund, L., Ellis, V. & Dano, K.: Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J. Biol. Chem., 267, 18224-18229 (1992)
51. Hoyer-Hansen, G., Behrendt, N., Ploug, M., Dano, K. & Preissner, K.T.: The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction. FEBS Letters, 420, 79-85 (1997) (Pubitemid 28037204)
52. Sidenius, N., Sier, C.F.M. & Blasi, F.: Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo. FEBS Letters, 475, 52-56 (2000) (Pubitemid 30331077)
53. Koolwijk, P., Sidenius, N., Peters, E., Sier, C.F.M., Hanemaaijer, R., Blasi, F. & van Hinsbergh, V.W.M.: Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices Blood, 97, 3123-3131 (2001)
54. Beaufort, N., Leduc, D., Eguchi, H., Mengele, K., Hellmann, D., Masegi, T., Kamimura, T., Yasuoka, S., Fend, F., Chignard, M. & Pidard, D.: The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions Am J Physiol Lung Cell Mol Physiol, 292, 1263-1272 (2007)
55. Beaufort, N., Debela, M., Creutzburg, S., Kellermann, J., Bode, W., Schmitt, M., Pidard, D. & Magdolen, V.: Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structureand functions of the urokinase-type plasminogen activator receptor (uPAR). Biol Chem., 387, 217-22 (2006) (Pubitemid 43221836)
56. Beaufort, N., Leduc, D., Rousselle, J.-C., Magdolen, V., Luther, T., Namane, A., Chignard, M. & Pidard, D.: Proteolytic Regulation of the Urokinase Receptor/CD87 on Monocytic Cells by Neutrophil Elastase and Cathepsin G J Immunol, 172, 540-549 (2004) (Pubitemid 38020511)
57. Ke, S.-H., Coombs, G.S., Tachias, K., Corey, D.R. & Madison, E.L.: Optimal Subsite Occupancy and Design of a Selective Inhibitor of Urokinase J. Biol. Chem., 272, 20456-20462 (1997) (Pubitemid 27355599)
58. Ploug, M., Ellis, V. & Dano, K.: Ligand Interaction between Urokinase-Type Plasminogen Activator and Its Receptor Probed with 8-Anilino-1-naphthalenesulfonate. Evidence for a Hydrophobic Binding Site Exposed Only on the Intact Receptor. Biochemistry, 33, 8991-8997 (1994) (Pubitemid 24258008)
59. Sidenius, N. & Blasi, F.: Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin. FEBS Letters, 470, 40-46 (2000) (Pubitemid 30155620)
60. Selleri, C., Montuori, N., Ricci, P., Visconte, V., Carriero, M.V., Sidenius, N., Serio, B., Blasi, F., Rotoli, B., Rossi, G. & Ragno, P.: Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood, 105, 2198-205 (2005) (Pubitemid 40731813)
61. Resnati, M., Guttinger, M., Valcamonica, S., Sidenius, N., Blasi, F. & Fazioli, F.: Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. Embo J, 15, 1572-82 (1996) (Pubitemid 26112379)
62. Resnati, M., Pallavicini, I., Wang, J.M., Oppenheim, J., Serhan, C.N., Romano, M. & Blasi, F.: The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci U S A, 99, 1359-64 (2002) (Pubitemid 34136498)
63. Montuori, N., Visconte, V., Rossi, G. & Ragno, P.: Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules? Thromb Haemost., 92, 192-8 (2005) (Pubitemid 40253721)
64. Ploug, M. & Ellis, V.: Structure-function relationships in the receptor for urokinase-type plasminogen activator Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins. FEBS Letters, 349, 163-168 (1994)
65. Ploug, M.: Structure-Function Relationships in the Interaction Between the Urokinase-Type Plasminogen Activator and Its Receptor. Curr Pharm Des., 9, 1499-528 (2003) (Pubitemid 36758313)
66. Low, B.W., Preston, H.S., Sato, A., Rosen, L.S., Searl, J.E., Rudko, A.D. & Richardson, J.S.: Three dimensional structure of erabutoxin b neurotoxic protein: inhibitor of acetylcholine receptor. Proc Natl Acad Sci U S A., 73, 2991-4 (1976)
67. Craik, C.S., Sprang, S., Fletterick, R. & Rutter, W.J.: Intron-exon splice junctions map at protein surfaces. Nature, 299, 180-2 (1982) (Pubitemid 12056801)
68. Dewan, J.C., Grant, G.A. & Sacchettini, J.C.: Crystal structure of kappa-bungarotoxin at 2.3. Å resolution. Biochemistry, 33, 13147-54 (1994)
69. Fletcher, C.M., Harrison, R.A., Lachmann, P.J. & Neuhaus, D.: Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. Structure, 2, 185-99 (1994)
70. Pawlak, J., Mackessy, S.P., Fry, B.G., Bhatia, M., Mourier, G., Fruchart-Gaillard, C., Servent, D., Menez, R., Stura, E., Menez, A. & Kini, R.M.: Denmotoxin, a threefinger toxin from the colubrid snake Boiga dendrophila (Mangrove Catsnake) with bird-specific activity. J Biol Chem, 281, 29030-41 (2006) (Pubitemid 44507047)
71. Torres, A.M., Kini, R.M., Selvanayagam, N. & Kuchel, P.W.: NMR structure of bucandin, a neurotoxin from the venom of the Malayan krait (Bungarus candidus). Biochem J, 360, 539-48 (2001) (Pubitemid 34020258)
72. Petranka, J., Zhao, J., Norris, J., N.B., T., Ware, R.E., Sims, P.J. & Rosse, W.F.: Structure-function relationships of the complement regulatory protein, CD59. Blood Cells Mol Dis., 22, 281-96 (1996) (Pubitemid 27492090)
73. Grant, G.A., Luetje, C.W., Summers, R. & Xu, X.L.: Differential Roles for Disulfide Bonds in the Structural Integrity and Biological Activity of kappa-Bungarotoxin, a Neuronal Nicotinic Acetylcholine Receptor Antagonist. Biochemistry, 37, 12166-12171 (1998) (Pubitemid 28411301)
74. Servent, D., Winckler-Dietrich, V., Hu, H.Y., Kessler, P., Drevet, P., Bertrand, D. & Menez, A.: Only snake curaremimetic toxins with a fifth disulfide bond have high affinity for the neuronal alpha7 nicotinic receptor. J Biol Chem, 272, 24279-86 (1997) (Pubitemid 27418630)
75. Suh, T., Nerlov, C., Dano, K. & Degen, J.: The murine urokinase-type plasminogen activator receptor gene. J. Biol. Chem., 269, 25992-25998 (1994) (Pubitemid 24328403)
76. Casey, J., Petranka, J., Kottra, J., Fleenor, D. & Rosse, W.: The structure of the urokinase-type plasminogen activator receptor gene. Blood, 84, 1151-1156 (1994) (Pubitemid 24245879)
77. Noel, L.S., Champion, B.R., Holley, C.L., Simmons, C.J., Morris, D.C., Payne, J.A., Lean, J.M., Chambers, T.J., Zaman, G., Lanyon, L.E., Suva, L.J. & Miller, L.R.: RoBo-1, a novel member of the urokinase plasminogen activator receptor/CD59/Ly-6/snake toxin family selectively expressed in rat bone and growth plate cartilage. J Biol Chem, 273, 3878-83 (1998) (Pubitemid 28103244)
78. Lizano, S., Angulo, Y., Lomonte, B., Fox, J.W., Lambeau, G., Lazdunski, M. & Gutierrez, J.M.: Two phospholipase A2 inhibitors from the plasma of Cerrophidion (Bothrops) godmani which selectively inhibit two different group-II phospholipase A2 myotoxins from its own venom: isolation, molecular cloning and biological properties. Biochem J, 346 Pt 3, 631-9 (2000) (Pubitemid 30171023)
79. Okumura, K., Masui, K., Inoue, S., Ikeda, K. & Hayashi, K.: Purification, characterization and cDNA cloning of a phospholipase A2 inhibitor from the serum of the non-venomous snake Elaphe quadrivirgata. Biochem J, 341 ( Pt 1), 165-71 (1999) (Pubitemid 29359061)
80. Rösel, M., Claas, C., Seiter, S., Herlevsen, M. & Zöller, M.: Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor. Oncogene, 17, 1989-2002 (1998) (Pubitemid 28488468)
81. Seiter, S., Stassar, M., Rappl, G., Reinhold, U., Tilgen, W. & Zöller, M.: Upregulation of C4.4A Expression During Progression of Melanoma, J Invest Dermatol 116, 344-347 (2001) (Pubitemid 32173741)
82. Hansen, L., Lærum, O., Illemann, M., Nielsen, B. & Ploug, M.: Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma. Int J Cancer, 122, 734-41 (2007)
83. Hansen, L.V., Skov, B.G., Ploug, M. & Pappot, H.: Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer. Lung Cancer, 58, 260-6 (2007) (Pubitemid 47516689)
84. Hansen, L.V., Gardsvoll, H., Nielsen, B.S., Lund, L.R., Dano, K., Jensen, O.N. & Ploug, M.: Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor. Biochem. J., 380, 845-857 (2004) (Pubitemid 38850527)
85. Klippel, S., Strunck, E., Roder, S., Lubbert, M., Lange, W., Azemar, M., Meinhardt, G., Schaefer, H.-E. & Pahl, H.L.: Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood, 95, 2569-2576 (2000) (Pubitemid 30210535)
86. Takayama, T., Mishima, T., Mori, M., Jin, H., Tsukamoto, H., Takahashi, K., Takizawa, T., Kinoshita, K., Suzuki, M., Sato, I., Matsubara, S., Araki, Y. & Takizawa, T.: Sexually Dimorphic Expression of the Novel Germ Cell Antigen TEX101 During Mouse Gonad Development Biol Reprod, 72, 1315-1323 (2005) (Pubitemid 40696074)
87. Ploug, M., Ostergaard, S., Gardsvoll, H., Kovalski, K., Holst-Hansen, C., Holm, A., Ossowski, L. & Dano, K.: Peptide-Derived Antagonists of the Urokinase Receptor. Affinity Maturation by Combinatorial Chemistry, Identification of Functional Epitopes, and Inhibitory Effect on Cancer Cell Intravasation. Biochemistry, 40, 12157-12168 (2001) (Pubitemid 32946557)
88. Jorgensen, T.J., Gardsvoll, H., Dano, K., Roepstorff, P. & Ploug, M.: Dynamics of urokinase receptor interaction with Peptide antagonists studied by amide hydrogen exchange and mass spectrometry. Biochemistry, 43, 15044-57 (2004) (Pubitemid 39587481)
89. Yuan, C. & Huang, M.: Does the urokinase receptor exist in a latent form? Cellular and Molecular Life Sciences (CMLS), 64, 1033-1037 (2007) (Pubitemid 46684549)
90. Ploug, M., Rahbek-Nielsen, H., Ellis, V., Roepstorff, P. & Dano, K.: Chemical Modification of the Urokinase-Type Plasminogen Activator and Its Receptor Using Tetranitromethane. Evidence for the Involvement of Specific Tyrosine Residues in Both Molecules during Receptor-Ligand Interaction. Biochemistry, 34, 12524-12534 (1995)
91. Waltz, D. & Chapman, H.: Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem., 269, 14746-14750 (1994) (Pubitemid 24194041)
92. Wei, Y., Waltz, D., Rao, N., Drummond, R., Rosenberg, S. & Chapman, H.: Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem., 269, 32380-32388 (1994)
93. Carriero, M.V., Vecchio, S.D., Capozzoli, M., Franco, P., Fontana, L., Zannetti, A., Botti, G., D'Aiuto, G., Salvatore, M. & Stoppelli, M.P.: Urokinase Receptor Interacts with alphavbeta5 Vitronectin Receptor, Promoting Urokinase-dependent Cell Migration in Breast Cancer. Cancer Res, 59, 5307-5314 (1999) (Pubitemid 29503999)
94. Wei, Y., Eble, J.A., Wang, Z., Kreidberg, J.A. & Chapman, H.A.: Urokinase Receptors Promote beta1 Integrin Function through Interactions with Integrin alpha3beta1. Mol. Biol. Cell, 12, 2975-2986 (2001) (Pubitemid 33062955)
95. Wei, Y., Lukashev, M., Simon, D.I., Bodary, S.C., Rosenberg, S., Doyle, M.V. & Chapman, H.A.: Regulation of Integrin Function by the Urokinase Receptor Science, 273, 1551-1555 (1996) (Pubitemid 26301666)
96. Wei, Y., Czekay, R.P., Robillard, L., Kugler, M.C., Zhang, F., Kim, K.K., Xiong, J.P., Humphries, M.J. & Chapman, H.A.: Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding. J Cell Biol, 168, 501-11 (2005) (Pubitemid 40205071)
97. Chaurasia, P., Aguirre-Ghiso, J.A., Liang, O.D., Gardsvoll, H., Ploug, M. & Ossowski, L.: A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth. J Biol Chem, 281, 14852-63 (2006) (Pubitemid 43855190)
98. Behrendt, N., Jensen, O.N., Engelholm, L.H., Mortz, E., Mann, M. & Dano, K.: A urokinase receptor-associated protein with specific collagen binding properties. J Biol Chem, 275, 1993-2002 (2000) (Pubitemid 30060826)
99. Colman, R.W., Pixley, R.A., Najamunnisa, S., Yan, W., Wang, J., Mazar, A. & McCrae, K.R.: Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J Clin Invest, 100, 1481-7 (1997) (Pubitemid 27425773)
100. Ploug, M., Laurenborg Hansen, L.B., Holm, A. & Dano, K.: Photoaffinity Labeling of the Human Receptor for Urokinase-Type Plasminogen Activator Using a Decapeptide Antagonist. Evidence for a Composite Ligand-Binding Site and a Short Interdomain Separation. Biochemistry, 37, 3612-3622 (1998) (Pubitemid 28162916)
101. Ellis, V.: Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase. J Biol Chem, 271, 14779-84 (1996)
102. Parry, M.A., Zhang, X.C. & Bode, I.: Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues. Trends Biochem Sci, 25, 53-9 (2000) (Pubitemid 30100366)
103. Marcotte, P.A., Kozan, I.M., Dorwin, S.A. & Ryan, J.M.: The matrix metalloproteinase pump-1 catalyzes formation of low molecular weight (pro)urokinase in cultures of normal human kidney cells. J Biol Chem, 267, 13803-6 (1992)
104. Spraggon, G., Phillips, C., Nowak, U.K., Ponting, C.P., Saunders, D., Dobson, C.M., Stuart, D.I. & Jones, E.Y.: The crystal structure of the catalytic domain of human urokinase-type plasminogen activator. Structure, 3, 681-691 (1995)
105. Zhao, G., Yuan, C., Wind, T., Huang, Z., Andreasen, P.A. & Huang, M.: Structural basis of specificity of a peptidyl urokinase inhibitor, upain-1. J Struct Biol 160, 1-10 (2007) (Pubitemid 47405230)
106. Rockway, T.W. & Giranda, V.L.: Inhibitors of the proteolytic activity of urokinase type plasminogen activator. Curr Pharm Des, 9, 1483-98 (2003) (Pubitemid 36758312)
107. Appella, E., Robinson, E., Ullrich, S., Stoppelli, M., Corti, A., Cassani, G. & Blasi, F.: The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. J. Biol. Chem., 262, 4437-4440 (1987) (Pubitemid 17102801)
108. Magdolen, V., Rettenberger, P., Koppitz, M., Goretzki, L., Kessler, H., Weidle, U.H., König, B., Graeff, H., Schmitt, M. & Wilhelm, O.: Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator. Eur J Biochem, 237, 743-51 (1996) (Pubitemid 26157664)
109. Burgle, M., Koppitz, M., Riemer, C., Kessler, H., König, B., Weidle, U.H., Kellermann, J., Lottspeich, F., Graeff, H., Schmitt, M., Goretzki, L., Reuning, U., Wilhelm, O. & Magdolen, V.: Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptides. Biol Chem, 378, 231-7 (1997) (Pubitemid 27230608)
110. Schmiedeberg, N., Schmitt, M., Rolz, C., Truffault, V., Sukopp, M., Burgle, M., Wilhelm, O.G., Schmalix, W., Magdolen, V. & Kessler, H.: Synthesis, solution structure, and biological evaluation of urokinase type plasminogen activator (uPA)-derived receptor binding domain mimetics. J Med Chem, 45, 4984-94 (2002) (Pubitemid 35278694)
111. Hansen, A.P., Petros, A.M., Meadows, R.P., Nettesheim, D.G., Mazar, A.P., Olejniczak, E.T., Xu, R.X., Pederson, T.M., Henkin, J. & Fesik, S.W.: Solution Structure of the Amino-Terminal Fragment of Urokinase-Type Plasminogen Activator. Biochemistry, 33, 4847-4864 (1994) (Pubitemid 24158434)
112. Nowak, U.K., Li, X., Teuten, A.J., Smith, R.A.G. & Dobson, C.M.: NMR studies of the dynamics of the multidomain protein urokinase-type plasminogen activator. Biochemistry, 32, 298-309 (1993) (Pubitemid 23033349)
113. Oswald, R.E., Bogusky, M.J., Bamberger, M., Smith, R.A.G. & Dobson, C.M.: Dynamics of the multidomain fibrinolytic protein urokinase from two-dimensional NMR, Nature 337, 579-582 (1989) (Pubitemid 19045547)
114. Novokhatny, V., Medved, L., Mazar, A., Marcotte, P., Henkin, J. & Ingham, K.: Domain structure and interactions of recombinant urokinase-type plasminogen activator. J. Biol. Chem., 267, 3878-3885 (1992)
115. Hansen, A.P., Petros, A.M., Meadows, R.P. & Fesik, S.W.: Backbone Dynamics of a Two-Domain Protein: 15N Relaxation Studies of the Amino-Terminal Fragment of Urokinase-Type Plasminogen Activator. Biochemistry, 33, 15418-15424 (1994)
116. Huang, M., Mazar, A.P., Parry, G., Higazi, A.A.-R., Kuo, A. & Cines, D.B.: Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase aminoterminal fragment (1-143) Acta Crystallographica Section D, 61, 697-700 (2005) (Pubitemid 43951510)
117. Gardsvoll, H., Gilquin, B., Le Du, M.H., Menéz, A., Jorgensen, T.J.D. & Ploug, M.: Characterization of the Functional Epitope on the Urokinase Receptor: Complete Alanine Scanning Mutagenesis Supplemented by Chemical Cross-linking J. Biol. Chem., 281, 19260-19272 (2006) (Pubitemid 44035430)
118. Bdeir, K., Kuo, A., Sachais, B.S., Rux, A.H., Bdeir, Y., Mazar, A., Higazi, A.A. & Cines, D.B.: The kringle stabilizes urokinase binding to the urokinase receptor. Blood, 102, 3600-8 (2003) (Pubitemid 37409377)
119. Waltz, D.A., Sailor, L.Z. & Chapman, H.A.: Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. J Clin Invest., 91, 1541-52 (1993) (Pubitemid 23127356)
120. Chang, A.W., Kuo, A., Barnathan, E.S. & Okada, S.S.: Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase. Arterioscler Thromb Vasc Biol, 18, 1855-60 (1998) (Pubitemid 28565746)
121. Kanse, S.M., Kost, C., Wilhelm, O.G., Andreasen, P.A. & Preissner, K.T.: The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res, 224, 344-53 (1996) (Pubitemid 26140568)
122. Gardsvoll, H. & Ploug, M.: Mapping of the vitronectin binding site on the urokinase receptor. Involvement of a coherent receptor interface comprising residues from both domain I and the flanking interdomain linker region J. Biol. Chem., 282, 13561-13572 (2007) (Pubitemid 47100512)
123. Sidenius, N., Andolfo, A., Fesce, R. & Blasi, F.: Urokinase Regulates Vitronectin Binding by Controlling Urokinase Receptor Oligomerization. J. Biol. Chem., 277, 27982-27990 (2002) (Pubitemid 34966747)
124. Kjoller, L.: The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility. Biol Chem., 383, 5-19 (2002) (Pubitemid 34224024)
125. Madsen, C.D., Ferraris, G.M., Andolfo, A., Cunningham, O. & Sidenius, N.: uPAR-induced cell adhesion and migration: vitronectin provides the key. J Cell Biol, 177, 927-39 (2007) (Pubitemid 46873097)
126. Salasznyk, R.M., Zappala, M., Zheng, M., Yu, L., Wilkins-Port, C. & McKeown-Longo, P.J.: The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells. Matrix Biol, 26, 359-70 (2007) (Pubitemid 46803257)
127. Preissner, K.T. & Seiffert, D.: Role of vitronectin and its receptors in haemostasis and vascular remodeling. Thromb Res, 89, 1-21 (1998) (Pubitemid 28231482)
128. Lynn, G.W., Heller, W.T., Mayasundari, A., Minor, K.H. & Peterson, C.B.: A model for the three-dimensional structure of human plasma vitronectin from small-angle scattering measurements. Biochemistry, 44, 565-74 (2005) (Pubitemid 40105487)
129. Horn, N.A., Hurst, G.B., Mayasundari, A., Whittemore, N.A., Serpersu, E.H. & Peterson, C.B.: Assignment of the Four Disulfides in the N-terminal Somatomedin B Domain of Native Vitronectin Isolated from Human Plasma. J. Biol. Chem., 279, 35867-35878 (2004) (Pubitemid 39100594)
130. Kamikubo, Y., Kroon, G., Curriden, S.A., Dyson, H.J. & Loskutoff, D.J.: The Reduced, Denatured Somatomedin B Domain of Vitronectin Refolds into a Stable, Biologically Active Molecule. Biochemistry, 45, 3297-3306 (2006) (Pubitemid 43376348)
131. Kamikubo, Y.-i., Okumura, Y. & Loskutoff, D.J.: Identification of the Disulfide Bonds in the Recombinant Somatomedin B Domain of Human Vitronectin. J. Biol. Chem., 277, 27109-27119 (2002) (Pubitemid 34951725)
132. Li, X., Zou, G., Yuan, W. & Lu, W.: Defining the Native Disulfide Topology in the Somatomedin B Domain of Human Vitronectin J. Biol. Chem., 282, 5318-5326 (2007) (Pubitemid 47093733)
133. Zhou, A.: Functional structure of the somatomedin B domain of vitronectin. Protein Sci, 16, 1502-8 (2007) (Pubitemid 46984885)
134. Kamikubo, Y., DeGuzman, R., Kroon, G., Curriden, S., Neels, J.G., Churchill, M.J., Dawson, P., Oldziej, S., Jagielska, A., Scheraga, H.A., Loskutoff, D.J. & Dyson, H.J.: Disulfide Bonding Arrangements in Active Forms of the Somatomedin B Domain of Human Vitronectin. Biochemistry, 43, 6519-6534 (2004) (Pubitemid 38697551)
135. Kjaergaard, M., Gardsvoll, H., Hirschberg, D., Nielbo, S., Mayasundari, A., Peterson, C.B., Jansson, A., Jorgensen, T.J., Poulsen, F.M. & Ploug, M.: Solution structure of recombinant somatomedin B domain from vitronectin produced in Pichia pastoris. Protein Sci, 16, 1934-45 (2007) (Pubitemid 47367116)
136. Mayasundari, A., Whittemore, N.A., Serpersu, E.H. & Peterson, C.B.: The Solution Structure of the N-terminal Domain of Human Vitronectin: Proximal Sites That Regulate Fibrinolysis and Cell Migration. J. Biol. Chem., 279, 29359-29366 (2004) (Pubitemid 38915814)
137. Zhou, A., Huntington, J.A., Pannu, N.S., Carrell, R.W. & Read, R.J.: How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. Nat Struct Biol., 10, 541-544 (2003) (Pubitemid 36792905)
138. Deng, G., Curriden, S., Wang, S., Rosenberg, S. & Loskutoff, D.: Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? . J. Cell Biol., 134, 1563-1571 (1996) (Pubitemid 26318027)
139. Waltz, D.A., Natkin, L.R., Fujita, R.M., Wei, Y. & Chapman, H.A.: Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J Clin Invest, 100, 58-67 (1997) (Pubitemid 27311243)
140. Stefansson, S. & Lawrence, D.A.: The serpin PAI-1 inhibits cell migration by blocking integrin aVb3 binding to vitronectin. Nature, 383, 441-3 (1996) (Pubitemid 26330833)
141. Okumura, Y., Kamikubo, Y., Curriden, S.A., Wang, J., Kiwada, T., Futaki, S., Kitagawa, K. & Loskutoff, D.J.: Kinetic Analysis of the Interaction between Vitronectin and the Urokinase Receptor J. Biol. Chem., 277, 9395-9404 (2002) (Pubitemid 34953025)
142. Moser, T.L., Enghild, J.J., Pizzo, S.V. & Stack, M.S.: Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. Biochem J., 307, 867-73 (1995)